Arrowhead Pharmaceuticals, Inc. ( (ARWR) ) has released its Q4 earnings. Here is a breakdown of the information Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global ...

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...

Live webcasts of these presentations can be accessed by visiting “Investor Events” on the Investor Relations section of the Wave Life Sciences website: ...

Shares of Arrowhead Pharmaceuticals ($ARWR) surged as much as 22% in pre-market trading on Tuesday after announcing a $825 ...

HAYWARD, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based ...

The company is working with a Nucleic Acid Therapy Accelerator in the U.K. to more quickly develop cancer drugs.

For instance, promising technologies such as marker-assisted breeding, gene editing & CRISPR, biosensors, and GMO-free RNA interference are leading innovations in this sector. The marker-assisted ...

RNA therapeutics promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will ...

Researchers have used whole-genome CRISPR interference screening to identify the “Achilles Heel” of drug-resistant ...

Built around research by Stanford scientist Carolyn Bertozzi and MIT researcher Jessica Stark, Valora Therapeutics is ...

GRAND CAYMAN, CAYMAN ISLANDS, . (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA ...